Literature DB >> 10792291

Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency.

E Grunebaum1, J Zhang, H Dadi, C M Roifman.   

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is characterized by destruction of haematopoietic elements, and is associated with a variety of manifestations including immune abnormalities. We describe an infant with HLH who had no evidence of infection or malignancy. He had markedly reduced natural killer (NK) and T-cell numbers and mitogen responses, consistent with severe combined immune deficiency. Western blot and flow cytometry analyses revealed an absence of interleukin (IL)-2 receptor gamma (gamma common) chain expression and a transition (C --> T) at nucleotide 684 in the gamma common gene. This novel case highlights the need for a thorough evaluation of immunological phenotype and genotype in patients with HLH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792291     DOI: 10.1046/j.1365-2141.2000.01923.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.

Authors:  Zuzana Tothova; Nancy Berliner
Journal:  J Intensive Care Med       Date:  2014-01-08       Impact factor: 3.510

2.  The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.

Authors:  Sebastian Fn Bode; Sandra Ammann; Waleed Al-Herz; Mihaela Bataneant; Christopher C Dvorak; Stephan Gehring; Andrew Gennery; Kimberly C Gilmour; Luis I Gonzalez-Granado; Ute Groß-Wieltsch; Marianne Ifversen; Jenny Lingman-Framme; Susanne Matthes-Martin; Rolf Mesters; Isabelle Meyts; Joris M van Montfrans; Jana Pachlopnik Schmid; Sung-Yun Pai; Pere Soler-Palacin; Uta Schuermann; Volker Schuster; Markus G Seidel; Carsten Speckmann; Polina Stepensky; Karl-Walter Sykora; Bianca Tesi; Thomas Vraetz; Catherine Waruiru; Yenan T Bryceson; Despina Moshous; Kai Lehmberg; Michael B Jordan; Stephan Ehl
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

3.  Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.

Authors:  Matthew P Strout; Stuart Seropian; Nancy Berliner
Journal:  Nat Rev Clin Oncol       Date:  2010-04-20       Impact factor: 66.675

Review 4.  Human T cell immunodeficiency: when signal transduction goes wrong.

Authors:  Eyal Grunebaum; Nigel Sharfe; Chaim M Roifman
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Features of Hemophagocytic Lymphohistiocytosis in Infants With Severe Combined Immunodeficiency: Our Experience From Chandigarh, North India.

Authors:  Pandiarajan Vignesh; Gummadi Anjani; Rajni Kumrah; Ankita Singh; Sanjib Mondal; Johnson Nameirakpam; Ankur Jindal; Deepti Suri; Madhubala Sharma; Gurjit Kaur; Sathish Sharma; Kirti Gupta; Sreejesh Sreedharanunni; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

6.  X-linked severe combined immunodeficiency due to a novel mutation complicated with hemophagocytic lymphohistiocytosis and presented with invagination: A case report.

Authors:  Turkan Patiroglu; H Haluk Akar; Mirjam van den Burg; Ekrem Unal; Basak N Akyildiz; Nazan U Tekerek; Ebru Yilmaz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-09-11

Review 7.  Signal-transduction defects in T cells.

Authors:  E Grunebaum; C M Roifman
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.